Our group studies allosteric regulation mechanisms in the protein kinases. We use unique biophysical approaches to define 1) how conformational changes of key structural elements regulate the normal function of kinases, 2) how this regulation is disrupted in cancer, and 3) how these allosteric effects alter inhibitor recognition and can be exploited for improved inhibitor design.